Table 3 Distribution of studied patients according to changes in eligiblity for BCS before and after chemotherapy
From: Neoadjuvant chemotherapy for stage II–III breast cancer: a single-center experience
After chemotherapy | Total | |||
|---|---|---|---|---|
Eligible | Ineligible | |||
Before chemotherapy | Eligible (Row%, Grand Total%) | 58 (87.9%, 39.5%) | 8 (12.1%, 5.4%) | 66 (100%, 44.9%) |
Ineligible (Row%, Grand Total%) | 40 (49.4, 27.2%) | 41 (50.6%, 27.9%) | 81 (100%, 55.1%) | |
Total | 98 (66.7%) | 49 (33.3%) | 147 | |